INAB
Price
$4.17
Change
+$4.05 (+3375.00%)
Updated
Jun 6 closing price
Capitalization
329.77M
60 days until earnings call
SRZN
Price
$8.50
Change
-$0.14 (-1.62%)
Updated
Jun 6 closing price
Capitalization
73.98M
Interact to see
Advertisement

INAB vs SRZN

Header iconINAB vs SRZN Comparison
Open Charts INAB vs SRZNBanner chart's image
IN8bio
Price$4.17
Change+$4.05 (+3375.00%)
Volume$528.25K
Capitalization329.77M
Surrozen
Price$8.50
Change-$0.14 (-1.62%)
Volume$1.18K
Capitalization73.98M
INAB vs SRZN Comparison Chart
Loading...
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INAB vs. SRZN commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INAB is a Hold and SRZN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (INAB: $0.14 vs. SRZN: $7.89)
Brand notoriety: INAB and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INAB: 235% vs. SRZN: 12%
Market capitalization -- INAB: $329.77M vs. SRZN: $73.98M
INAB [@Biotechnology] is valued at $329.77M. SRZN’s [@Biotechnology] market capitalization is $73.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INAB’s FA Score shows that 1 FA rating(s) are green whileSRZN’s FA Score has 0 green FA rating(s).

  • INAB’s FA Score: 1 green, 4 red.
  • SRZN’s FA Score: 0 green, 5 red.
According to our system of comparison, INAB is a better buy in the long-term than SRZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INAB’s TA Score shows that 5 TA indicator(s) are bullish while SRZN’s TA Score has 6 bullish TA indicator(s).

  • INAB’s TA Score: 5 bullish, 3 bearish.
  • SRZN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SRZN is a better buy in the short-term than INAB.

Price Growth

INAB (@Biotechnology) experienced а +12.70% price change this week, while SRZN (@Biotechnology) price change was +7.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

INAB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INAB($330M) has a higher market cap than SRZN($74M). INAB (-44.790) and SRZN (-45.031) have similar YTD gains . SRZN has higher annual earnings (EBITDA): -25.06M vs. INAB (-26.94M). SRZN has more cash in the bank: 31M vs. INAB (11.1M). SRZN has less debt than INAB: SRZN (1.53M) vs INAB (5.03M). SRZN has higher revenues than INAB: SRZN (10M) vs INAB (0).
INABSRZNINAB / SRZN
Capitalization330M74M446%
EBITDA-26.94M-25.06M108%
Gain YTD-44.790-45.03199%
P/E RatioN/AN/A-
Revenue010M-
Total Cash11.1M31M36%
Total Debt5.03M1.53M329%
TECHNICAL ANALYSIS
Technical Analysis
INABSRZN
RSI
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
79%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
78%
MACD
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 11 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
79%
Bearish Trend 11 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
84%
Advances
ODDS (%)
Bullish Trend about 1 month ago
80%
Bullish Trend 19 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
84%
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

INAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INAB has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INAB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INAB
1D Price
Change %
INAB100%
-1.32%
IDYA - INAB
47%
Loosely correlated
+0.72%
SRZN - INAB
39%
Loosely correlated
+3.11%
HURA - INAB
36%
Loosely correlated
+9.18%
GRI - INAB
35%
Loosely correlated
+3.05%
SNSE - INAB
33%
Loosely correlated
-4.53%
More

SRZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRZN has been loosely correlated with RNTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SRZN jumps, then RNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+3.11%
RNTX - SRZN
44%
Loosely correlated
-2.00%
INAB - SRZN
39%
Loosely correlated
-1.32%
IRON - SRZN
34%
Loosely correlated
-1.66%
KMSTF - SRZN
34%
Loosely correlated
N/A
ELDN - SRZN
31%
Poorly correlated
N/A
More